Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Breakthrough T1D Formely JDRF

Establishing Immune Tolerance in Islet Cell Replacement Therapy for Type 1 Diabetes (T1D)

Last update: Nov 24, 2025 Last update: Nov 24, 2025

Details

Location:Worldwide
Worldwide
Funding agency:
Nonprofit organization
Contracting authority: Breakthrough T1D Formely JDRF
Contracting authority type:NGO
Status:Open
Budget:N/A
Award ceiling: USD 900,000
Award floor:N/A
Sector:Health, Research & Innovation
Languages:English
Eligible applicants:NGOs / Nonprofit Organisations, Government / Public Bodies, Academic Institutions, Private Sector
Eligible citizenships:Worldwide
Worldwide
Date posted: Nov 24, 2025

Attachments • 0

Associated Awards

Description

Establishing Immune Tolerance in Islet Cell Replacement Therapy for Type 1 Diabetes (T1D)The Breakthrough T1D is requesting applications to support the development of tolerance induction approaches for islet cell therapy that enables graft-specific immune
Want to unlock full information?
Member-only information. Become a member to access this information. Procurement notices from over 850+ sources of tenders and grants published by donors, development banks, foundations, and international financial institutions (IFIs) are available here.
Learn more about our membership benefits
Print